Lck is a key target of imatinib and dasatinib in T-cell activation

Research output: Contribution to journal › Letter › peer-review

76 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{d2ac57963dea41a6b4c7f8eec10c03e6,

title = "Lck is a key target of imatinib and dasatinib in T-cell activation",

author = "Lee, {K. C.} and I. Ouwehand and Giannini, {A. L.} and Thomas, {N. S.} and Dibb, {N. J.} and Bijlmakers, {M. J.}",

year = "2010",

month = apr,

doi = "10.1038/leu.2010.11",

language = "English",

volume = "24",

pages = "896 -- 900",

journal = "Leukemia",

issn = "1476-5551",

publisher = "Springer Nature [academic journals on nature.com]",

number = "4",

}